Osteoporosis: Romosozumab approved for use by the NHS – cause

Study says pregnant women shouldn’t delay getting Covid vaccine until late pregnancy
Fluoride side effects: Seven side effects to your health caused by this substance

The CEO continued: “The decision to approve the new drug is a reminder that there are safe, effective therapies and treatment options available to help prevent fractures and enable people to live well with the disease. Osteoporosis.”

Still, Jones said there are still some issues to work out: “The next important step is to end the postcode lottery for fracture communication services, which remains a difficult barrier to viability. timely diagnosis and treatment of people.

“Closing the visual treatment gap for osteoporosis depends on ending inequalities in local services across the NHS.”

Meanwhile, osteoporosis is more likely to occur in later life because “you gradually start to lose bone from around age 35”, the NHS said.

Source: | This article first appeared on

Source link


News7F: Update the world's latest breaking news online of the day, breaking news, politics, society today, international mainstream news .Updated news 24/7: Entertainment, the World everyday world. Hot news, images, video clips that are updated quickly and reliably

Related Articles

Back to top button